📈 The Top Analysis for CRISPR Therapeutics AG (CRSP)

CRISPR Therapeutics: A Turning Point for the Gene Editing Pioneer
Image

Welcome back to AI Analysis! If you're passionate about investing in the future of medicine, you’re in the right place. Today, we’ll be analyzing CRISPR Therapeutics (Ticker: CRSP), the biotech pioneer that’s making waves in gene editing treatments.

🎯 What is the Current Sentiment for CRSP?

The current sentiment is slightly bullish📈
1 top investor currently rates CRSP a buy

🔥 Which Investors Rated CRSP a Buy?

💸 CRISPR Therapeutics AG (CRSP) - What is the Conversation?

Check out the top conversations on CRSP
Image

General 05/30/2025

Image

General 05/30/2025

Image

General 01/07/2025

CRSP
CRISPR Therapeutics AG
Market Cap
$3,874,301,440.00
52 Week High
$91.10
PE Ratio
-9.19
52 Week Low
$37.55
EPS
-$3.20
Shares Outstanding
85,168,200.00
Dividend Yield
-
Dividend Per Share
-
PoweredByInsightfulIR
Resources for Publishers
Resources for New Investors
Stock Selection Guides (SSG) - A New Investor Guide
BetterInvesting™ Resources
Partner Resources
The Top Stock Selection Guide Picks
Understanding the Stock Selection Guide


Utility Stocks - A New Investor Guide
Best Utility Stocks to Invest in


Value Investing - Strategy Basics
Resources
Is Value Investing Right for you?
Implementing a Value Strategy


A Guide to Metaverse Stocks
How to Invest
How the Metaverse Makes Money
Metaverse Investment Analysis


A Guide to Industrial Stocks


A Guide to Finance Stocks


A Guide to Healthcare Stocks
How to Invest
Which is a Better Buy in Healthcare?
Critical Healthcare Stocks Analyzed


A Guide to Material Stocks


A Guide to Telecom Stocks